Blog
Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for
Pacira (PCRX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Premier, Inc. (PINC) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Premier, Inc. (PINC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Ferrari (RACE) Earnings Expected to Grow: Should You Buy?
The market expects Ferrari (RACE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Qualys (QLYS) Earnings Expected to Grow: Should You Buy?
The market expects Qualys (QLYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Par Petroleum (PARR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Leidos (LDOS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Leidos (LDOS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
LCI (LCII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
LCI (LCII) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Lemonade (LMND) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Jazz Pharmaceuticals (JAZZ) reports results for the quarter ended March 2025. While this widely-known consensus
Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Lucid Group (LCID) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
Krystal Biotech, Inc. (KRYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
The market expects J&J Snack Foods (JJSF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when IPG Photonics (IPGP) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Ingredion (INGR) Earnings Expected to Grow: Should You Buy?
The market expects Ingredion (INGR) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when International General Insurance Holdings Ltd. (IGIC) reports results for the quarter ended March 2025. While this
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Intapp (INTA) Earnings Expected to Grow: Should You Buy?
The market expects Intapp (INTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Forrester Research (FORR) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know
Forge Global Holdings, Inc. (FRGE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know
Genius Sports Limited (GENI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Helios Technologies (HLIO) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Halozyme Therapeutics (HALO) reports results for the quarter ended March 2025. While this widely-known consensus
Expeditors International (EXPD) Earnings Expected to Grow: Should You Buy?
The market expects Expeditors International (EXPD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
The market expects Esperion Therapeutics (ESPR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
Enlight Renewable Energy Ltd. (ENLT) Earnings Expected to Grow: Should You Buy?
The market expects Enlight Renewable Energy Ltd. (ENLT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This